Home ›
Entities
› academia
› Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312)
Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312)
Research article (Clinical Cancer Research, 2019) · cited 66× · AI/ML
Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312)
Summary
Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312) is a scholarly article[1].
Key Facts
Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312)'s instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312). Retrieved May 24, 2026, from https://4ort.xyz/entity/phase-i-clinical-trial-of-the-wee1-inhibitor-adavosertib-azd1775-with-irinotecan-in-children-with-relapsed-solid-tumors-
MLA“Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312).” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/phase-i-clinical-trial-of-the-wee1-inhibitor-adavosertib-azd1775-with-irinotecan-in-children-with-relapsed-solid-tumors-.
BibTeX@misc{4ortxyz_phase-i-clinical-trial-of-the-wee1-inhibitor-adavosertib-azd1775-with-irinotecan-in-children-with-relapsed-solid-tumors-_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312)}}, year = {2026}, url = {https://4ort.xyz/entity/phase-i-clinical-trial-of-the-wee1-inhibitor-adavosertib-azd1775-with-irinotecan-in-children-with-relapsed-solid-tumors-}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312) — https://4ort.xyz/entity/phase-i-clinical-trial-of-the-wee1-inhibitor-adavosertib-azd1775-with-irinotecan-in-children-with-relapsed-solid-tumors- (retrieved 2026-05-24)
